Fmr LLC grew its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 49.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,992,096 shares of the company’s stock after acquiring an additional 2,316,813 shares during the period. Fmr LLC’s holdings in Avantor were worth $147,323,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB grew its stake in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after buying an additional 625 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC lifted its stake in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. boosted its holdings in shares of Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after purchasing an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC bought a new position in shares of Avantor during the 4th quarter valued at about $65,000. 95.08% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In related news, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. This trade represents a 10.78 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at approximately $1,531,753.87. This trade represents a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Read Our Latest Report on Avantor
Avantor Stock Performance
Shares of AVTR stock opened at $15.21 on Monday. The firm has a market capitalization of $10.37 billion, a price-to-earnings ratio of 14.63, a PEG ratio of 1.55 and a beta of 1.24. The stock has a fifty day moving average of $16.80 and a 200 day moving average of $20.44. Avantor, Inc. has a 52 week low of $13.80 and a 52 week high of $28.00. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54.
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the previous year, the business posted $0.22 earnings per share. As a group, research analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current year.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
- Five stocks we like better than Avantor
- Canada Bond Market Holiday: How to Invest and Trade
- Is McDonald’s Stock Serving a Value Meal to Investors?
- Investing in the High PE Growth Stocks
- Walgreens Comeback? Private Equity Circling for a Buyout
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.